Current and future antiplatelet therapies: emphasis on preserving haemostasis
Current and future antiplatelet therapies: emphasis on preserving haemostasis
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Antiplatelet agents form a cornerstone of therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention, as well as in the secondary prevention of cardiovascular events
Currently available antiplatelet agents, including cyclooxygenase 1 inhibitors, P2Y purinoreceptor 12 (P2Y
12
) antagonists,...
Alternative Titles
Full title
Current and future antiplatelet therapies: emphasis on preserving haemostasis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1984243596
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1984243596
Other Identifiers
ISSN
1759-5002
E-ISSN
1759-5010
DOI
10.1038/nrcardio.2017.206
